GlassScriptPhysician profile
Sarah Guo
NPI 1174225577
$3,790.96
in general payments reported to CMS, 2019-2025
9 companies · $2,821 in 2025
The $2,821 reported for 2025 was more than what 96% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $310 · 2024: $660 · 2025: $2,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,250 · Food and Beverage: $1,088 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,250.00 |
| Food and Beverage | $1,088.25 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $2,500.00 | 2025 | |
| Abbvie INC. | $241.67 | 2024-2025 | |
| Genentech USA, INC. | $134.09 | 2024 | Vabysmo |
| Amgen INC. | $126.17 | 2024 | Tepezza |
| Apellis Pharmaceuticals, INC. | $120.79 | 2024 | Syfovre |
| Mallinckrodt Hospital Products INC. | $118.91 | 2025 | Acthar |
| Regeneron Healthcare Solutions, INC. | $107.79 | 2024 | Eylea Hd |
| Alcon Vision LLC | $63.36 | 2025 | Centurion |
| Ani Pharmaceuticals, INC. | $25.46 | 2025 | Yutiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Guo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.